Abstract
Background
Alcohol-induced liver cirrhosis is one of the leading indications for liver transplantation today. Due to the general organ shortage and continuous deaths on the waiting list there has been some debate on the issue of indication and ethical problems. It was the aim of this study to critically analyse the outcome of patients with alcoholic cirrhosis transplanted at our centre with special emphasis on alcohol-recurrence frequency and long-term histological follow-up.
Methods
Three hundred five patients who received LT for alcoholic cirrhosis at our institution were followed over a period of 3–10 years after transplantation. Biopsies were taken 1, 3, 5, and 10 years after LT. Specimens were analysed and staged concerning inflammation, rejection, fatty involution, and fibrosis/cirrhosis. Clinical characteristics as well as serological parameters, immunosuppressive protocols, rejection episodes, and patient and graft survival were recorded.
Results
Recurrence of alcohol abuse occurred in 27% of all patients analysed. Regardless of alcohol consumption, 5-year graft and patient survival were excellent; after 10 years abstinent patients showed significantly better survival (82% vs. 68%; P = 0.017). Histological changes were slightly more pronounced among recurrent drinkers, no significant difference regarding inflammation or fibrosis was detected.
Conclusion
Patients undergoing LT for alcohol-induced cirrhosis show excellent long-term survival rates with stable graft function. Alcohol recurrence impairs long-term prognosis; however, compared to other patient sub-populations (HCC, HCV) results are clearly above average.
Similar content being viewed by others
Abbreviations
- LT:
-
Liver transplantation
- ALD:
-
Alcoholic liver disease
- HCC:
-
Hepatocellular carcinoma
- HCV:
-
Hepatitis C
- HBV:
-
Hepatitis B
- CNI:
-
Calcineurin inhibitors
- CyA:
-
Cyclosporine A
- Tac:
-
Tacrolimus
- AST:
-
Aspartate amino transferase
- ALT:
-
Alanine amino transferase
- GGT:
-
Gamma glutamyl transferase
- AP:
-
Alkaline phosphatase
- GLDH:
-
Glutamate dehydrogenase
- INR:
-
International standard normalized ratio
- MELD:
-
Model of end stage liver disease
References
Roberts MS, Angus DC, Bryce CL, Valenta Z, Weissfeld L. Survival after liver transplantation in the United States: A disease-specific analysis of the UNOS database. Liver Transpl. 2004;10:886–897.
Yao FY, Saab S, Bass NM, et al. Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scores. Hepatology. 2004;39:230–238.
Mutimer DJ, Gunson B, Chen J, et al. Impact of donor age and year of transplantation on graft and patient survival following liver transplantation for hepatitis C virus. Transplantation. 2006;81:7–14.
Neuberger J, Adams D, MacMaster P, Maidment A, Speed M. Assessing priorities for allocation of donor liver grafts: Survey of public and clinicians. BMJ. 1998;317:172–175.
Dixon J, Welch HG. Priority setting: Lessons from Oregon. Lancet. 1991;337:891–894.
Mandayam S, Jamal MM, Morgan TR. Epidemiology of alcoholic liver disease. Semin Liver Dis. 2004;24:217–232.
Lim JK, Keeffe EB. Liver transplantation for alcoholic liver disease: Current concepts and length of sobriety. Liver Transpl. 2004;10:S31–S38.
Berlakovich GA. Wasting your organ with your lifestyle and receiving a new one? Ann Transplant. 2005;10:38–43.
O’Grady JG. Liver transplantation alcohol related liver disease: (deliberately) stirring a hornet’s nest! Gut. 2006;55:1529–1531.
Miguet M, Monnet E, Vanlemmens C, et al. Predictive factors of alcohol relapse after orthotopic liver transplantation for alcoholic liver disease. Gastroenterol Clin Biol. 2004;28:845–851.
Perney P, Bismuth M, Sigaud H, et al. Are preoperative patterns of alcohol consumption predictive of relapse after liver transplantation for alcoholic liver disease? Transpl Int. 2005;18:1292–1297.
Tome S, Martinez-Rey C, Gonzalez-Quintela A, et al. Influence of superimposed alcoholic hepatitis on the outcome of liver transplantation for end-stage alcoholic liver disease. J Hepatol. 2002;36:793–798.
Bjornsson E, Olsson J, Rydell A, et al. Long-term follow-up of patients with alcoholic liver disease after liver transplantation in Sweden: Impact of structured management on recidivism. Scand J Gastroenterol. 2005;40:206–216.
Bahra M, Neumann UP, Jacob D, et al. Outcome after liver re-transplantation in patients with recurrent chronic hepatitis C. Transpl Int. 2007;20:771–778.
Berenguer M, Prieto M, Palau A, et al. Severe recurrent hepatitis C after liver retransplantation for hepatitis C virus-related graft cirrhosis. Liver Transpl. 2003;9:228–235.
Neumann UP, Berg T, Bahra M, et al. Long-term outcome of liver transplants for chronic hepatitis C: A 10-year follow-up. Transplantation. 2004;77:226–231.
Pfitzmann R, Schwenzer J, Rayes N, Seehofer D, Neuhaus R, Nussler NC. Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease. Liver Transpl. 2007;13:197–205.
Pageaux GP, Bismuth M, Perney P, et al. Alcohol relapse after liver transplantation for alcoholic liver disease: Does it matter? J Hepatol. 2003;38:629–634.
Cescon M, Grazi GL, Ercolani G, et al. Long-term survival of recipients of liver grafts from donors older than 80 years: Is it achievable? Liver Transpl. 2003;9:1174–1180.
Nardo B, Masetti M, Urbani L, et al. Liver transplantation from donors aged 80 years and over: Pushing the limit. Am J Transplant. 2004;4:1139–1147.
Nardo B, Montalti R, Beltempo P, et al. Octogenarian livers successfully transplanted in patients with fulminant hepatic failure. Transplant Proc. 2005;37:389–391.
Gastaca M, Valdivieso A, Pijoan J, et al. Donors older than 70 years in liver transplantation. Transplant Proc. 2005;37:3851–3854.
Zapletal C, Faust D, Wullstein C, et al. Does the liver ever age? Results of liver transplantation with donors above 80 years of age. Transplant Proc. 2005;37:1182–1185.
Busuttil RW, Tanaka K. The utility of marginal donors in liver transplantation. Liver Transpl. 2003;9:651–663.
Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: The concept of a donor risk index. Am J Transplant. 2006;6:783–790.
Schaubel DE, Sima CS, Goodrich NP, Feng S, Merion RM. The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplant. 2008;8(2):419–425.
Busquets J, Xiol X, Figueras J, et al. The impact of donor age on liver transplantation: Influence of donor age on early liver function and on subsequent patient and graft survival. Transplantation. 2001;71:1765–1771.
Rifai K, Sebagh M, Karam V, et al. Donor age influences 10-year liver graft histology independently of hepatitis C virus infection. J Hepatol. 2004;41:446–453.
Roayaie K, Feng S. Allocation policy for hepatocellular carcinoma in the MELD era: Room for improvement? Liver Transpl. 2007;13:S36–S43.
Piscaglia F, Camaggi V, Ravaioli M, et al. A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system. Liver Transpl. 2007;13:857–866.
Fisher RA, Kulik LM, Freise CE, et al. Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Am J Transplant. 2007;7:1601–1608.
Amin MG, Wolf MP, TenBrook JA Jr, et al. Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: A decision analysis. Liver Transpl. 2004;10:1468–1475.
Merion RM, Schaubel DE, Dykstra DM, Freeman RB, Port FK, Wolfe RA. The survival benefit of liver transplantation. Am J Transplant. 2005;5:307–313.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schmeding, M., Heidenhain, C., Neuhaus, R. et al. Liver Transplantation for Alcohol-Related Cirrhosis: A Single Centre Long-Term Clinical and Histological Follow-Up. Dig Dis Sci 56, 236–243 (2011). https://doi.org/10.1007/s10620-010-1281-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-010-1281-7